{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T06:31:56Z","timestamp":1757313116340},"reference-count":25,"publisher":"Tottori University Faculty of Medicine","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Yonago Acta Med."],"published-print":{"date-parts":[[2021]]},"DOI":"10.33160\/yam.2021.05.014","type":"journal-article","created":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T22:13:52Z","timestamp":1621462432000},"page":"200-206","source":"Crossref","is-referenced-by-count":2,"title":["Role of Cell-Origin Profiling Using Immunohistochemistry to Predict the Survival of Patients with Diffuse Large B-Cell Lymphoma in Indonesia"],"prefix":"10.33160","volume":"64","author":[{"given":"Hermawan","family":"Istiadi","sequence":"first","affiliation":[{"name":"Anatomical Pathology Department, Faculty of Medicine, Diponegoro University, Semarang 50244, Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Udadi","family":"Sadhana","sequence":"additional","affiliation":[{"name":"Anatomical Pathology Department, Faculty of Medicine, Diponegoro University, Semarang 50244, Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dik","family":"Puspasari","sequence":"additional","affiliation":[{"name":"Anatomical Pathology Laboratory, Kariadi General Hospital, Semarang 50244, Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ika Pawitra","family":"Miranti","sequence":"additional","affiliation":[{"name":"Anatomical Pathology Department, Faculty of Medicine, Diponegoro University, Semarang 50244, Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vega","family":"Karlowee","sequence":"additional","affiliation":[{"name":"Anatomical Pathology Department, Faculty of Medicine, Diponegoro University, Semarang 50244, Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devia Eka","family":"Listiana","sequence":"additional","affiliation":[{"name":"Anatomical Pathology Laboratory, Kariadi General Hospital, Semarang 50244, Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Awal","family":"Prasetyo","sequence":"additional","affiliation":[{"name":"Anatomical Pathology Department, Faculty of Medicine, Diponegoro University, Semarang 50244, Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18656","reference":[{"key":"1","unstructured":"1. Globocan.iarc.fr. Cancer Fact Sheet [Internet]. Lyon; 2018 [cited 2019 Sep 9]. Available from: https:\/\/globocan.iarc.fr\/"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127:2375-90. PMID:26980727, DOI:10.1182\/blood-2016-01-643569","DOI":"10.1182\/blood-2016-01-643569"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Habara T, Sato Y, Takata K, Iwaki N, Okumura H, Sonobe H, et al. Germinal center B-cell-like versus non-germinal center B-cell-like as important prognostic factor for localized nodal DLBCL. J Clin Exp Hematop. 2012;52:91-9. PMID:23037624, DOI:10.3960\/jslrt.52.91","DOI":"10.3960\/jslrt.52.91"},{"key":"4","unstructured":"4. Syahrin RA, Ham MF, Harahap AS, Makes B, Hardjolukito ESR. Perbedaan Imunoekspresi Caspase-3 Antara Diffuse Large B-Cell Lymphoma Subtipe Germinal Center B-Cell-Like dan Non-Germinal Center B-Cell-Like. Indones J Pathol. 2018;27:1-6. Epub 2018 Feb 20."},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Read JA, Koff JL, Nastoupil LJ, Williams JN, Cohen JB, Flowers CR. Evaluating cell-of-origin subtype methods for predicting diffuse large B-cell lymphoma survival: a meta-analysis of gene expression profiling and immunohistochemistry algorithms. Clin Lymphoma Myeloma Leuk. 2014;14:460-467.e2. PMID:25052052, DOI:10.1016\/j.clml.2014.05.002","DOI":"10.1016\/j.clml.2014.05.002"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Testoni M, Zucca E, Young KH, Bertoni F. Genetic lesions in diffuse large B-cell lymphomas. Ann Oncol. 2015;26:1069-80. PMID:25605746, DOI:10.1093\/annonc\/mdv019","DOI":"10.1093\/annonc\/mdv019"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Camicia R, Winkler HC, Hassa PO. Novel drug targets for personalized precision medicine in relapsed\/refractory diffuse large B-cell lymphoma: a comprehensive review. Mol Cancer. 2015;14:207. PMID:26654227, DOI:10.1186\/s12943-015-0474-2","DOI":"10.1186\/s12943-015-0474-2"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004;103:275-82. PMID:14504078, DOI:10.1182\/blood-2003-05-1545","DOI":"10.1182\/blood-2003-05-1545"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Wang XJ, Seegmiller AC, Reddy NM, Li S. CD30 expression and its correlation with MYC rearrangement in de novo diffuse large B-cell lymphoma. Eur J Haematol. 2016;97:39-47. PMID:26340843, DOI:10.1111\/ejh.12680","DOI":"10.1111\/ejh.12680"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Yoo C, Kim S, Sohn BS, Kim JE, Yoon DH, Huh J, et al. Modified number of extranodal involved sites as a prognosticator in R-CHOP-treated patients with disseminated diffuse large B-cell lymphoma. Korean J Intern Med. 2010;25:301-8. PMID:20830228, DOI:10.3904\/kjim.2010.25.3.301","DOI":"10.3904\/kjim.2010.25.3.301"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Sehn LH, Gascoyne RD. Diffuse large B-cell lymphoma: optimizing outcome in the context of clinical and biologic heterogeneity. Blood. 2015;125:22-32. PMID:25499448, DOI:10.1182\/blood-2014-05-577189","DOI":"10.1182\/blood-2014-05-577189"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Hwang HS, Yoon DH, Hong JY, Park CS, Lee YS, Ko YH, et al. The cell-of-origin classification of diffuse large B cell lymphoma in a Korean population by the Lymph2Cx assay and its correlation with immunohistochemical algorithms. Ann Hematol. 2018;97:2363-72. PMID:30069703, DOI:10.1007\/s00277-018-3442-2","DOI":"10.1007\/s00277-018-3442-2"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Klapper W, Kreuz M, Kohler CW, Burkhardt B, Szczepanowski M, Salaverria I, et al.; Molecular Mechanisms in Malignant Lymphomas Network Project of the Deutsche Krebshilfe. Patient age at diagnosis is associated with the molecular characteristics of diffuse large B-cell lymphoma. Blood. 2012;119:1882-7. PMID:22238326, DOI:10.1182\/blood-2011-10-388470","DOI":"10.1182\/blood-2011-10-388470"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Zhou Z, Sehn LH, Rademaker AW, Gordon LI, LaCasce AS, Crosby-Thompson A, et al. An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. Blood. 2014;123:837-42. PMID:24264230, DOI:10.1182\/blood-2013-09-524108","DOI":"10.1182\/blood-2013-09-524108"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Li S, Young KH, Medeiros LJ. Diffuse large B-cell lymphoma. Pathology. 2018;50:74-87. PMID:29167021, DOI:10.1016\/j.pathol.2017.09.006","DOI":"10.1016\/j.pathol.2017.09.006"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Bruno Ventre M, Ferreri AJM, Gospodarowicz M, Govi S, Messina C, Porter D, et al.; International Extranodal Lymphoma Study Group. Clinical features, management, and prognosis of an international series of 161 patients with limited-stage diffuse large B-cell lymphoma of the bone (the IELSG-14 study). Oncologist. 2014;19:291-8. PMID:24567283, DOI:10.1634\/theoncologist.2013-0249","DOI":"10.1634\/theoncologist.2013-0249"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Gogia A, Das CK, Kumar L, Sharma A, Tiwari A, Sharma MC, et al. Diffuse large B-cell lymphoma: an institutional analysis. South Asian J Cancer. 2018;07:200-2. PMID:30112341, DOI:10.4103\/sajc.sajc_65_18","DOI":"10.4103\/sajc.sajc_65_18"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. Abdelhamid T, Samra M, Ramadan H, Mehessin M, Mokhtar N. Clinical prognostic factors of diffuse large B cell non-Hodgkin lymphoma: A retrospective study. J Egypt Natl Canc Inst. 2011;23:17-24. PMID:22099932, DOI:10.1016\/j.jnci.2011.07.003","DOI":"10.1016\/j.jnci.2011.07.003"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Salles G, de Jong D, Xie W, Rosenwald A, Chhanabhai M, Gaulard P, et al. Prognostic significance of immunohistochemical biomarkers in diffuse large B-cell lymphoma: a study from the Lunenburg Lymphoma Biomarker Consortium. Blood. 2011;117:7070-8. PMID:21536860, DOI:10.1182\/blood-2011-04-345256","DOI":"10.1182\/blood-2011-04-345256"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20. Hwang HS, Park CS, Yoon DH, Suh C, Huh J. High concordance of gene expression profiling-correlated immunohistochemistry algorithms in diffuse large B-cell lymphoma, not otherwise specified. Am J Surg Pathol. 2014;38:1046-57. PMID:24705314, DOI:10.1097\/PAS.0000000000000211","DOI":"10.1097\/PAS.0000000000000211"},{"key":"21","doi-asserted-by":"publisher","unstructured":"21. Li T, Medeiros LJ, Lin P, Yin H, Littlejohn M, Im W, et al. Immunohistochemical profile and fluorescence in situ hybridization analysis of diffuse large B-cell lymphoma in northern China. Arch Pathol Lab Med. 2010;134:759-65. PMID:20441508, DOI:10.5858\/134.5.759","DOI":"10.5858\/134.5.759"},{"key":"22","doi-asserted-by":"publisher","unstructured":"22. Lu TX, Miao Y, Wu JZ, Gong QX, Liang JH, Wang Z, et al. The distinct clinical features and prognosis of the CD10+MUM1+ and CD10\u2212Bcl6\u2212MUM1\u2212 diffuse large B-cell lymphoma. Sci Rep. 2016;6:20465. PMID:26857366, DOI:10.1038\/srep20465","DOI":"10.1038\/srep20465"},{"key":"23","doi-asserted-by":"publisher","unstructured":"23. Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, Fisher RI, et al.; Lymphoma\/Leukemia Molecular Profiling Project. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med. 2002;346:1937-47. PMID:23067219, DOI:10.4149\/neo_2013_010","DOI":"10.4149\/neo_2013_010"},{"key":"24","doi-asserted-by":"publisher","unstructured":"24. Lohr JG, Stojanov P, Lawrence MS, Auclair D, Chapuy B, Sougnez C, et al. Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing. Proc Natl Acad Sci USA. 2012;109:3879-84. PMID:22343534, DOI:10.1073\/pnas.1121343109","DOI":"10.1073\/pnas.1121343109"},{"key":"25","doi-asserted-by":"publisher","unstructured":"25. Rossi D, Ciardullo C, Gaidano G. Genetic aberrations of signaling pathways in lymphomagenesis: revelations from next generation sequencing studies. Semin Cancer Biol. 2013;23:422-30. PMID:23665546, DOI:10.1016\/j.semcancer.2013.04.002","DOI":"10.1016\/j.semcancer.2013.04.002"}],"container-title":["Yonago Acta Medica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yam\/64\/2\/64_2021.05.014\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,22]],"date-time":"2021-05-22T04:02:09Z","timestamp":1621656129000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yam\/64\/2\/64_2021.05.014\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.33160\/yam.2021.05.014","relation":{},"ISSN":["1346-8049"],"issn-type":[{"value":"1346-8049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]}}}